Bristol-Myers Squibb Company BMY
NYSE
Recommendation
Dividend Power Score
Day's Range
$62.99$65.54
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 50.03B | 49.19B | 48.48B | 48.19B | 48.03B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 50.03B | 49.19B | 48.48B | 48.19B | 48.03B |
| Cost of Revenue | 14.76B | 13.94B | 13.58B | 13.19B | 12.90B |
| Gross Profit | 35.27B | 35.25B | 34.90B | 35.00B | 35.14B |
| SG&A Expenses | 7.22B | 7.31B | 7.17B | 7.15B | 6.91B |
| Depreciation & Amortization | 2.16B | 2.53B | 2.92B | 3.32B | 4.18B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 33.84B | 33.55B | 33.18B | 33.15B | 33.71B |
| Operating Income | 16.20B | 15.64B | 15.31B | 15.05B | 14.32B |
| Income Before Tax | 11.33B | 11.91B | 9.60B | 9.33B | 8.03B |
| Income Tax Expenses | 2.09B | 2.63B | 2.32B | 2.27B | 1.99B |
| Earnings from Continuing Operations | 9.24K | 9.28K | 7.27K | 7.06K | 6.05K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.00M | 7.00M | 4.00M | -1.00M | -6.00M |
| Net Income | 9.24B | 9.28B | 7.28B | 7.05B | 6.04B |
| EBIT | 16.20B | 15.64B | 15.31B | 15.05B | 14.32B |
| EBITDA | 18.79B | 18.94B | 18.98B | 19.12B | 19.23B |
| EPS Basic | 4.53 | 4.55 | 3.57 | 3.47 | 2.97 |
| Normalized Basic EPS | 4.95 | 4.87 | 4.84 | 4.86 | 4.45 |
| EPS Diluted | 4.51 | 4.54 | 3.56 | 3.45 | 2.96 |
| Normalized Diluted EPS | 4.93 | 4.86 | 4.83 | 4.85 | 4.44 |
| Average Basic Shares Outstanding | 8.16B | 8.15B | 8.15B | 8.14B | 8.13B |
| Average Diluted Shares Outstanding | 8.19B | 8.18B | 8.17B | 8.16B | 8.15B |
| Dividend Per Share | 2.52 | 2.51 | 2.50 | 2.49 | 2.48 |
| Payout Ratio | 55.38% | 54.89% | 69.69% | 71.52% | 82.81% |